PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
28-May-2020 Sareum to Present at BIO Digital 2020 Sareum
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec
28-May-2020 Laboratory relocation specialist backs NHS tribute Aport
28-May-2020 Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models Hubrecht Organoid Technology
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec Ltd
28-May-2020 Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation Cidara Therapeutics, Inc
28-May-2020 IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford IRBM Group
28-May-2020 Almac Group Supports Two COVID-19 Clinical Studies in Sub-Saharan Africa Almac Group
22-May-2020 Cherwell prepared media accessories help reduce risk in EM Cherwell Laboratories
22-May-2020 Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company Tiziana Life Sciences plc
21-May-2020 Mental health app Flow joins ORCHA App Library ORCHA
21-May-2020 Clinical trials company calls for unity and action to address lack of patient diversity in research Innovative Trials
21-May-2020 Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
21-May-2020 Yemen: In Aden’s only COVID-19 treatment centre we are seeing a catastrophe unfold Doctors Without Borders
21-May-2020 Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis Gilead
20-May-2020 Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003 Novadip Biosciences
20-May-2020 BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics BioMed X
20-May-2020 Alphega Pharmacy Members Receive Extra Support in Covid-19 Effort Alphega Pharmacy
20-May-2020 Prime Global announces acquisition of Cambridge Medical Communication Prime Global
20-May-2020 Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial Minoryx Therapeutics